Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
The California Plasma Coalition (CalPlasma) today launched a statewide campaign to raise awareness of the vital role that plasma donations play in saving lives of Californians and patients around the ...
Pfizer will end the global commercialisation of its haemophilia gene therapy Beqvez (fidanacogene elaparvovec) amid low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback